Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07464158 · ClinicalTrials.gov registry record · NA
WRITE: Written Imaginal Thinking Exercise Study
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 353
- Enrollment target
NCT07464158 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 353 participants.
The verdict
NCT07464158, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 353 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate and compare the effects of three different versions of a future imaginal writing exercise (worst-case scenario, neutral future scenario, best-case scenario) for individuals with elevated social anxiety symptoms. Participants (estimated N=270) will be recruited through the online platform, Prolific, and will be randomly assigned to one of three writing exercise conditions. Participants will complete three study sessions across approximately three weeks. Study session 1 (T1) will consist of baseline assessments and pre-writing ratings, a future imaginal writing exercise, and then post-writing ratings. Study session 2 (T2) will occur approximately one week later and will consist of mid-study assessments and pre-writing ratings, a second, repeated future imaginal writing exercise, and then post-writing ratings. Finally, study session 3 (T3) will occur approximately one week later (approximately two weeks after T1) and will consist of follow-up assessments and repeated post-writing ratings.
Interventions
- BEHAVIORAL Worst-Case Scenario Written Exposure Exercise
- BEHAVIORAL Neutral Future Scenario Written Exercise
- BEHAVIORAL Best-Case Scenario Written Exposure Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 353 participants |
| Start Date | 2026-03-21 |
| Est. Completion | 2026-06-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07464158
The ClinicalTrials.gov registry entry for NCT07464158 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 353 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Worst-Case Scenario Written Exposure Exercise is the first listed.
NCT07464158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07464158 about?
NCT07464158 is a clinical study titled "WRITE: Written Imaginal Thinking Exercise Study". The purpose of the study is to investigate and compare the effects of three different versions of a future imaginal writing exercise (worst-case scenario, neutral future scenario, best-case scenario) for individuals with elevated social anxiety symptoms. Participants (estimated N=270) will be recrui...
What is the current status of trial NCT07464158?
This trial is currently completed. It is a NA study. The enrollment target is 353 participants. The study started on 2026-03-21. Estimated completion is 2026-06-05.
What interventions are being tested in trial NCT07464158?
The interventions under investigation include: Worst-Case Scenario Written Exposure Exercise (BEHAVIORAL), Neutral Future Scenario Written Exercise (BEHAVIORAL), Best-Case Scenario Written Exposure Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT07464158?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.